Tatva Chintan Pharma Chem Ltd. (TATVA) 52 Week High Streak
- October 7, 2026
- Posted by: Chaitanya Auti
- Category: News
Tatva Chintan Pharma Chem Ltd. 52 Week High Streak has now run for the second straight session, with the stock trading within 2% of its 52-week high across the streak and advancing 5.24% over that span. The latest Univest data confirms the repeated-high pattern, but it does not establish a company-specific catalyst behind the move. As of 07 October 2026 at 9:22 AM IST, TATVA was trading at Rs 1,884.2, keeping it near the upper end of its yearly range.
The latest trade compared with a previous close of Rs 1,884.15, while the day opened at Rs 1,874.75 and moved between Rs 1,868.05 and Rs 1,898.25. Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,187.88 crore, which places the current Tatva Chintan Pharma Chem Ltd. 52 Week High Streak in the context of a company that is already trading close to its one-year peak rather than reacting to a single-session jump. For readers, the key signal is the persistence of the pattern across two sessions, not just the latest tick.
Tatva Chintan Pharma Chem Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,884.2 |
| Previous Close | Rs 1,884.15 |
| Today's Move | +Rs 0.05 (+0%) |
| Open | Rs 1,874.75 |
| High | Rs 1,898.25 |
| Low | Rs 1,868.05 |
| Market Capitalisation | Rs 4,187.88 crore |
Tatva Chintan Pharma Chem Ltd. (TATVA) traded at Rs 1,884.2 versus the previous close of Rs 1,884.15, a rise of 0%. The stock opened at Rs 1,874.75, reached a high of Rs 1,898.25 and touched a low of Rs 1,868.05.
Tatva Chintan Pharma Chem Ltd. share price today was almost unchanged from the previous close, with TATVA last traded at Rs 1,884.2 against Rs 1,884.15 yesterday. The intraday range stayed contained between Rs 1,868.05 and Rs 1,898.25, and the stock spent the morning near the upper part of that band. That keeps Tatva Chintan Pharma Chem Ltd. 52 Week High Streak relevant for readers tracking whether the near-high trade is holding or fading.
From a market-capitalisation lens, the company remains a Rs 4,187.88 crore business, so the price action is important mainly because it keeps the stock close to its yearly peak for a second straight session. The repeated trade near the top of the 52-week range can matter more than a one-day uptick because it shows that the stock is staying in the same price zone across consecutive sessions. For stock market readers searching for Tatva Chintan Pharma Chem Ltd. Share Price, this is a straightforward update: the move has been steady, the range has been tight, and the stock continues to trade near its 52-week high.
What the Repeated 52-Week Highs Show
The latest Tatva Chintan Pharma Chem Ltd. 52 Week High Streak shows persistence rather than a one-off move. A second straight session near the yearly high tells readers that the stock has remained in a tight area across two trading days, with a cumulative gain of 5.24% over the streak. That is the key differentiator versus a single-day breakout article.
There is no company-specific catalyst confirmed by the latest Univest data, so the repeated near-high trade should be read as a price pattern first and a story second. For investors tracking Tatva Chintan Pharma Chem Ltd. Stock News, the main point is that the market has continued to value the shares near their one-year peak. The latest move also keeps the stock in the broader set of Stocks Hitting 52 Week Highs and Stocks At One Year High Today, which often attracts attention from readers scanning Stocks In News Today and Top Gainers This Week.
Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,187.88 crore |
| P/E Ratio | 85.77x |
| P/B Ratio | 5.52x |
| ROE | 5.53% |
| ROCE | 7.17% |
| EPS | Rs 21.97 |
| Book Value Per Share | Rs 341.03 |
| Dividend Yield | 0.11% |
Tatva Chintan Pharma Chem Ltd. (TATVA) fundamental metrics show P/E 85.77x, P/B 5.52x, ROE 5.53%, ROCE 7.17%. These figures provide context only and are not a buy or sell signal.
Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,187.88 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 85.77x, P/B at 5.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 21.97, book value per share of Rs 341.03, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.21x, median ROE of 7.87%, median ROCE of 10.04%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Chemicals |
| Industry | Chemicals |
| Benchmark Scope | same industry |
| Company P/E Ratio | 85.77x |
| Benchmark Median P/E | 22.21x |
| Benchmark Average P/E | 43.25x |
| Benchmark P/E Range | 0x to 742.21x |
| Company P/B Ratio | 5.52x |
| Benchmark Median P/B | 1.92x |
| Company ROE | 5.53% |
| Benchmark Median ROE | 7.87% |
| Company ROCE | 7.17% |
| Benchmark Median ROCE | 10.04% |
| Company Market Capitalisation | Rs 4,187.88 crore |
| Benchmark Median Market Cap | Rs 483.38 crore |
Tatva Chintan Pharma Chem Ltd. (TATVA) is classified under sector: Chemicals and industry: Chemicals.
Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 85.77x, which is above the benchmark median of 22.21x, a difference of +286.18%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROE of 5.53%, which is below the benchmark median of 7.87%, a difference of -29.73%. Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 10.04%, a difference of -28.59%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Vishnu Chemicals Ltd. | VISHNU | 4,359 | 31.23 | 4.22 | 14.26 | 16.38 |
| Epigral Ltd. | EPIGRAL | 4,390.28 | 16.52 | 1.93 | 16.09 | 15.65 |
| Gujarat Alkalies And Chemicals Ltd. | GUJALKALI | 4,442.93 | 68.22 | 0.86 | -0.04 | 1.4 |
| Grauer & Weil (India) Ltd. | GRAUWEIL | 3,782.36 | 23.3 | 3.33 | 16.23 | 21.55 |
| Foseco India Ltd. | FOSECOIND | 4,728.42 | 67.27 | 4.51 | 10.87 | 15.35 |
Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 85.77x compared with the displayed peer median of 31.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 5.53% compares with a peer median of 14.26% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 15.65%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem Ltd. (TATVA) has a market capitalisation of Rs 4,187.88 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Tatva Chintan Pharma Chem Ltd.
- Tatva Chintan Pharma Chem Ltd. 52 Week High Streak has continued for a second straight session, keeping the stock near its yearly peak.
- The cumulative move across the streak is 5.24%, which is the main difference versus a single-day move in Tatva Chintan Pharma Chem Ltd. Share Price.
- The latest Univest figures confirm the repeated near-high price pattern, but no company-specific catalyst is established.
- Tatva Chintan Pharma Chem Ltd. Fundamental Analysis shows a high valuation compared with the chemicals peer median.
- The stock remains one of the more closely watched 52 Week High Stocks in the chemicals space.
About Tatva Chintan Pharma Chem Ltd.
Tatva Chintan Pharma Chem Ltd. operates in the chemicals industry and is listed on the NSE and BSE under the symbol TATVA. The company’s current market capitalisation is Rs 4,187.88 crore, placing it above the typical size of many names in the same industry. Its recent Tatva Chintan Pharma Chem Ltd. 52 Week High Streak has drawn attention because the stock continues to trade close to its one-year high while the broader market watches valuation, return ratios and peer positioning. For readers tracking Tatva Chintan Pharma Chem Ltd. Stock News, the company now sits at an important market-visible point.
In the chemicals space, Tatva Chintan Pharma Chem Ltd. remains a stock where Tatva Chintan Pharma Chem Ltd. Share Price Today, valuation metrics and sector comparison all matter together. The company’s P/E, P/B, ROE, ROCE, EPS and book value create the financial context, while the repeated near-high trade keeps it firmly on watch for market participants scanning Tatva Chintan Pharma Chem Ltd. Stock Analysis and Tatva Chintan Pharma Chem Ltd. Share Price Update.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What does Tatva Chintan Pharma Chem Ltd. 52 Week High Streak mean?
Ans. It means Tatva Chintan Pharma Chem Ltd. has traded within 2% of its 52-week high for a second straight session. The pattern shows the stock has stayed near its yearly peak across consecutive sessions rather than just touching that zone once.
How many sessions has TATVA stayed near its 52-week high?
Ans. According to latest Univest data, the streak is two sessions long. The article uses the second straight session label, which confirms repeated near-high trading across back-to-back sessions. The stock moved 0% so far today.
How much has Tatva Chintan Pharma Chem Ltd. moved across the streak?
Ans. The cumulative move across the streak is 5.24%. That figure captures the full near-high run and is more informative than looking only at the latest price change.
Has a company-specific catalyst been confirmed?
Ans. No. The latest Univest data confirms the repeated near-high price pattern, but it does not establish a company-specific reason for the move. Readers should treat the price behaviour as confirmed, while the cause remains unconfirmed.
Is Tatva Chintan Pharma Chem Ltd. expensive compared with peers?
Ans. On the numbers given, the stock trades at a higher P/E and P/B than the peer median for chemicals. That places it above the middle of the pack on valuation, even though some peers trade on similarly rich multiples.
What do the latest fundamentals show?
Ans. The company’s P/E is 85.77, P/B is 5.52, ROE is 5.53 and ROCE is 7.17. EPS stands at Rs 21.97 and book value at Rs 341.03, giving investors a full valuation and return-ratio snapshot.
Why is the market capitalisation important here?
Ans. Market capitalisation helps frame the stock’s size and how the market values the company. Tatva Chintan Pharma Chem Ltd. is valued at Rs 4,187.88 crore, which puts the near-high move into a broader company-size context.
What should investors monitor next?
Ans. Investors should track whether Tatva Chintan Pharma Chem Ltd. continues to trade near its yearly peak, whether fundamentals support the valuation premium, and whether any fresh company update changes the price pattern. The current streak remains a market signal, not a recommendation.
Track Tatva Chintan Pharma Chem Ltd. (TATVA) Share Price on Univest
Use Tatva Chintan Pharma Chem Ltd. (TATVA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.